Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria

por Barratt, Jonathan, Tumlin, James, Suzuki, Yusuke, Kao, Amy, Aydemir, Aida, Pudota, Kishore, Jin, Hulin, Gühring, Hans, Appel, Gerald
Publicado 2022

Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study

por Morand, Eric F, Isenberg, David A, Wallace, Daniel J, Kao, Amy H, Vazquez-Mateo, Cristina, Chang, Peter, Pudota, Kishore, Aranow, Cynthia, Merrill, Joan T
Publicado 2020